#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Fatal Cardiac Arrhythmia and Long-QT Syndrome in a New Form of Congenital Generalized Lipodystrophy with Muscle Rippling (CGL4) Due to Mutations


We investigated eight families with a novel subtype of congenital generalized lipodystrophy (CGL4) of whom five members had died from sudden cardiac death during their teenage years. ECG studies revealed features of long-QT syndrome, bradycardia, as well as supraventricular and ventricular tachycardias. Further symptoms comprised myopathy with muscle rippling, skeletal as well as smooth-muscle hypertrophy, leading to impaired gastrointestinal motility and hypertrophic pyloric stenosis in some children. Additionally, we found impaired bone formation with osteopenia, osteoporosis, and atlanto-axial instability. Homozygosity mapping located the gene within 2 Mbp on chromosome 17. Prioritization of 74 candidate genes with GeneDistiller for high expression in muscle and adipocytes suggested PTRF-CAVIN (Polymerase I and transcript release factor/Cavin) as the most probable candidate leading to the detection of homozygous mutations (c.160delG, c.362dupT). PTRF-CAVIN is essential for caveolae biogenesis. These cholesterol-rich plasmalemmal vesicles are involved in signal-transduction and vesicular trafficking and reside primarily on adipocytes, myocytes, and osteoblasts. Absence of PTRF-CAVIN did not influence abundance of its binding partner caveolin-1 and caveolin-3. In patient fibroblasts, however, caveolin-1 failed to localize toward the cell surface and electron microscopy revealed reduction of caveolae to less than 3%. Transfection of full-length PTRF-CAVIN reestablished the presence of caveolae. The loss of caveolae was confirmed by Atomic Force Microscopy (AFM) in combination with fluorescent imaging. PTRF-CAVIN deficiency thus presents the phenotypic spectrum caused by a quintessential lack of functional caveolae.


Vyšlo v časopise: Fatal Cardiac Arrhythmia and Long-QT Syndrome in a New Form of Congenital Generalized Lipodystrophy with Muscle Rippling (CGL4) Due to Mutations. PLoS Genet 6(3): e32767. doi:10.1371/journal.pgen.1000874
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1000874

Souhrn

We investigated eight families with a novel subtype of congenital generalized lipodystrophy (CGL4) of whom five members had died from sudden cardiac death during their teenage years. ECG studies revealed features of long-QT syndrome, bradycardia, as well as supraventricular and ventricular tachycardias. Further symptoms comprised myopathy with muscle rippling, skeletal as well as smooth-muscle hypertrophy, leading to impaired gastrointestinal motility and hypertrophic pyloric stenosis in some children. Additionally, we found impaired bone formation with osteopenia, osteoporosis, and atlanto-axial instability. Homozygosity mapping located the gene within 2 Mbp on chromosome 17. Prioritization of 74 candidate genes with GeneDistiller for high expression in muscle and adipocytes suggested PTRF-CAVIN (Polymerase I and transcript release factor/Cavin) as the most probable candidate leading to the detection of homozygous mutations (c.160delG, c.362dupT). PTRF-CAVIN is essential for caveolae biogenesis. These cholesterol-rich plasmalemmal vesicles are involved in signal-transduction and vesicular trafficking and reside primarily on adipocytes, myocytes, and osteoblasts. Absence of PTRF-CAVIN did not influence abundance of its binding partner caveolin-1 and caveolin-3. In patient fibroblasts, however, caveolin-1 failed to localize toward the cell surface and electron microscopy revealed reduction of caveolae to less than 3%. Transfection of full-length PTRF-CAVIN reestablished the presence of caveolae. The loss of caveolae was confirmed by Atomic Force Microscopy (AFM) in combination with fluorescent imaging. PTRF-CAVIN deficiency thus presents the phenotypic spectrum caused by a quintessential lack of functional caveolae.


Zdroje

1. GargA

2004 Acquired and inherited lipodystrophies. N Engl J Med 350 1220 1234

2. GargA

AgarwalAK

2009 Lipodystrophies: Disorders of adipose tissue biology. Biochim Biophys Acta 1791 507 513

3. MagreJ

DelepineM

KhalloufE

Gedde-DahlTJr

Van MaldergemL

2001 Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 28 365 370

4. AgarwalAK

AriogluE

De AlmeidaS

AkkocN

TaylorSI

2002 AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet 31 21 23

5. KimCA

DelepineM

BoutetE

El MourabitH

Le LayS

2008 Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J Clin Endocrinol Metab 93 1129 1134

6. CaoH

AlstonL

RuschmanJ

HegeleRA

2008 Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia. Lipids Health Dis 7:3.:3

7. RajabA

HeathcoteK

JoshiS

JefferyS

PattonM

2002 Heterogeneity for congenital generalized lipodystrophy in seventeen patients from Oman. Am J Med Genet 110 219 225

8. HeathcoteK

RajabA

MagreJ

SyrrisP

BestiM

2002 Molecular analysis of Berardinelli-Seip congenital lipodystrophy in Oman: evidence for multiple loci. Diabetes 51 1291 1293

9. SimhaV

AgarwalAK

AroninPA

IannacconeST

GargA

2008 Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability. Am J Med Genet A 146A 2318 2326

10. CrottiL

CelanoG

DagradiF

SchwartzPJ

2008 Congenital long QT syndrome. Orphanet J Rare Dis 3 18

11. SlaughterMH

LohmanTG

BoileauRA

HorswillCA

StillmanRJ

1988 Skinfold equations for estimation of body fatness in children and youth. Hum Biol 60 709 723

12. SinhaR

FischG

TeagueB

TamborlaneWV

BanyasB

2002 Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346 802 810

13. HayashiYK

MatsudaC

OgawaM

GotoK

TominagaK

2009 Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J Clin Invest 119 2623 2633

14. SeelowD

SchuelkeM

HildebrandtF

NurnbergP

2009 HomozygosityMapper-an interactive approach to homozygosity mapping. Nucleic Acids Res 37 W593 W599

15. SeelowD

SchwarzJM

SchuelkeM

2008 GeneDistiller-distilling candidate genes from linkage intervals. PLoS One 3 e3874 doi:10.1371/journal.pone.0003874

16. HillMM

BastianiM

LuetterforstR

KirkhamM

KirkhamA

2008 PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 132 113 124

17. BetzRC

SchoserBG

KasperD

RickerK

RamirezA

2001 Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 28 218 219

18. LiuL

BrownD

McKeeM

LebrasseurNK

YangD

2008 Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance. Cell Metab 8 310 317

19. AboulaichN

VainonenJP

StralforsP

VenerAV

2004 Vectorial proteomics reveal targeting, phosphorylation and specific fragmentation of polymerase I and transcript release factor (PTRF) at the surface of caveolae in human adipocytes. Biochem J 383 237 248

20. FrankPG

PavlidesS

CheungMW

DaumerK

LisantiMP

2008 Role of caveolin-1 in the regulation of lipoprotein metabolism. Am J Physiol Cell Physiol 295 C242 C248

21. ChenL

ChuW

XuY

ChenP

LaoF

2009 Time-series investigation of fused vesicles in microvessel endothelial cells with atomic force microscopy. Microsc Res Tech DOI 10.1002/jemt.20766

22. HuangPL

DawsonTM

BredtDS

SnyderSH

FishmanMC

1993 Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75 1273 1286

23. SatoY

SagamiI

ShimizuT

2004 Identification of caveolin-1-interacting sites in neuronal nitric-oxide synthase. Molecular mechanism for inhibition of NO formation. J Biol Chem 279 8827 8836

24. Garcia-CardenaG

MartasekP

MastersBS

SkiddPM

CouetJ

1997 Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem 272 25437 25440

25. SunadaY

OhiH

HaseA

OhiH

HosonoT

2001 Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity. Hum Mol Genet 10 173 178

26. LöhnM

FürstenauM

SagachV

ElgerM

SchulzeW

2000 Ignition of calcium sparks in arterial and cardiac muscle through caveolae. Circ Res 87 1034 1039

27. BalijepalliRC

KampTJ

2008 Caveolae, ion channels and cardiac arrhythmias. Prog Biophys Mol Biol 98 149 160

28. VorgerdM

BolzH

PatzoldT

KubischC

MalinJP

1999 Phenotypic variability in rippling muscle disease. Neurology 52 1453 1459

29. LambGD

2005 Rippling muscle disease may be caused by “silent” action potentials in the tubular system of skeletal muscle fibers. Muscle Nerve 31 652 658

30. HansenCG

BrightNA

HowardG

NicholsBJ

2009 SDPR induces membrane curvature and functions in the formation of caveolae. Nat Cell Biol 11 807 814

31. MedinaFA

WilliamsTM

SotgiaF

TanowitzHB

LisantiMP

2006 A novel role for caveolin-1 in B lymphocyte function and the development of thymus-independent immune responses. Cell Cycle 5 1865 1871

32. HartungA

Bitton-WormsK

RechtmanMM

WenzelV

BoergermannJH

2006 Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Mol Cell Biol 26 7791 7805

33. SawadaN

TaketaniY

AmizukaN

IchikawaM

OgawaC

2007 Caveolin-1 in extracellular matrix vesicles secreted from osteoblasts. Bone 41 52 58

34. MillerSA

DykesDD

PoleskyHF

1988 A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 1215

35. AllanVJ

2000 Basic immunofluorescence.

AllanVK

Protein localization by fluorescence mciroscopy Oxford Oxford University Press 1 26

36. PartonRG

MoleroJC

FloetenmeyerM

GreenKM

JamesDE

2002 Characterization of a distinct plasma membrane macrodomain in differentiated adipocytes. J Biol Chem 277 46769 46778

37. LuciusH

FriedrichsonT

KurzchaliaTV

LewinGR

2003 Identification of caveolae-like structures on the surface of intact cells using scanning force microscopy. J Membr Biol 194 97 108

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2010 Číslo 3
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#